Cargando…
Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia
BACKGROUND: The optimal duration of antibiotic treatment for community-acquired pneumonia (CAP) is not well established. The aim of this study was to assess the impact of reducing the duration of antibiotic treatment on long-term prognosis in patients hospitalized with CAP. METHODS: This was a multi...
Autores principales: | Uranga MD, Ane, Artaraz MD, Amaia, Bilbao MD, Amaia, Quintana MD, Jose María, Arriaga MD, Ignacio, Intxausti MD, Maider, Lobo MD, Jose Luis, García MD, Julia Amaranta, Camino MD, Jesus, España MD, Pedro Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538840/ https://www.ncbi.nlm.nih.gov/pubmed/33028293 http://dx.doi.org/10.1186/s12890-020-01293-6 |
Ejemplares similares
-
Correction to: Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia
por: Uranga, Ane, et al.
Publicado: (2021) -
Predicting 1-year mortality after hospitalization for community-acquired pneumonia
por: Uranga, Ane, et al.
Publicado: (2018) -
Diagnostic and therapeutic approach to occupational pneumonia
por: Yandiola, Pedro Pablo España, et al.
Publicado: (2022) -
Impact of severe lymphopenia on the early prediction of clinical outcome in hospitalized patients with pneumococcal community-acquired pneumonia
por: Ruiz, Luis A., et al.
Publicado: (2023) -
Utility of Differential White Cell Count and Cell Population Data for Ruling Out COVID-19 Infection in Patients With Community-Acquired Pneumonia
por: Uranga, Ane, et al.
Publicado: (2022)